Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism

Metabolism: Clinical and Experimental

Volumn 57, Issue 10, 2008, Pages 1380-1383

  Chu, Chih Hsun ^a,b,c   Lee, Jenn Kuen ^a,c   Wang, Mei Chun ^a   Lu, Chih Chen ^a,c   Sun, Chun Chin ^a   Chuang, Ming Ju ^a   Lam, Hing Chung ^a,c,d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Yuh Ing Junior College of Health Care and Management   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; C REACTIVE PROTEIN; CARBIMAZOLE; GLUCOSE; INSULIN; LIOTHYRONINE; PROPYLTHIOURACIL; THYROXINE; VISFATIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; GRAVES DISEASE; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LIOTHYRONINE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; THYROID FUNCTION;

ADULT; ANTITHYROID AGENTS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARBIMAZOLE; CYTOKINES; FEMALE; GRAVES DISEASE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROPYLTHIOURACIL; STATISTICS, NONPARAMETRIC; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 51649095379     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.006     Document Type: Article

References (27)

1. Weetman A.P. Graves' disease. N Engl J Med 343 (2000) 1236-1248
2. Duntas L.H. Thyroid disease and lipids. Thyroid 12 (2002) 287-293
3. Dimitriadis G.D., and Raptis S.A. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 109 Suppl 2 (2001) S225-S239
4. Yaturu S., Prado S., and Grimes S.R. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 93 (2004) 491-493
5. Nakamura T., Nagasaka S., Ishikawa S., et al. Association of hyperthyroidism with serum leptin levels. Metabolism 49 (2000) 1285-1288
6. Sesmilo G., Casamitjana R., Halperin I., et al. Role of thyroid hormones on serum leptin levels. Eur J Endocrinol 139 (1998) 428-430
7. Iglesias P., Fidalgot P.A., Codoceo R., et al. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 59 (2003) 621-629
8. Fukuhara A., Matsuda M., Nishizawa M., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
9. Samal B., Sun Y., Stearns G., et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony enhancing factor. Mol Cell Biol 14 (1994) 1431-1437
10. Kloting N., and Kloting I. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 332 (2005) 1070-1072
11. Kralisch S., Klein J., Lossner U., et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185 (2005) R1-R8
12. Celik I., Akalin S., and Erbas T. Serum levels of interleukin-6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol 132 (1995) 668-672
13. Komorowski J., Jankiewicz J., Robak T., et al. Cytokines serum levels as the markers of thyroid activation in Graves' disease. Immunol Lett 60 (1998) 143-148
14. Salvi M., Pedrazzoni M., Girasole G., et al. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 143 (2000) 197-202
15. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
16. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130 (1999) 671-680
17. Shamsuzzaman A.S.M., Winnicki M., Wolk R., et al. Independent association between plasma leptin and C reactive protein in healthy human. Circulation 109 (2004) 2181-2185
18. Chen H., Montagnani M., Funahahashi T., et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278 (2003) 45021-45026
19. Ouchi N., Kihara A., Arita Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
20. Ouchi N., Kihara S., Funahashi T., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
21. Kumada M., Kihara S., Ouchi N., et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109 (2004) 2046-2049
22. Aldhahi W., and Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 3 (2003) 293-298
23. Oki K., Yamane K., Kamei N., et al. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf). 67 (2007) 796-800
24. Wennlund A., Felig P., Hagenfeldt L., et al. Hepatic glucose production and splanchnic glucose exchange in hyperthyroidism. J Clin Endocrinol Metab 65 (1986) 174-180
25. Holness M., and Sugden M. Continued glucose output after re-feeding contributes to glucose intolerance in hyperthyroidism. Biochem J 247 (1987) 801-804
26. Mueller M., Paschen U., and Seitz H. Thyroid hormone regulation of glucose homeostasis in the miniature pig. Endocrinology 112 (1983) 2025-2031
27. Sandler M., Robinson R., Rabin D., et al. The effect of thyroid hormones on gluconeogenesis and forearm metabolism in man. J Clin Endocrinol Metab 56 (1983) 479-485